The PennZone

OWINGS MILLS, Md. - PennZone -- Today, the National Minority Health Association (NMHA) (https://www.thenmha.org). announced two important additions to its advisory board and leadership team.

Dyan Bryson will join the newly formed NMHA Industry Advisory Board and Victor Morrison will be installed as Vice President of Industry Relations. Both will focus on developing trusted relationships in underserved communities, improving clinical trial diversity, and maximizing the use of health tech, among other programs and initiatives as part of the NMHAs expansive health equity mission.  In her advisory board role, Dyan will provide valuable insights into the pharma industry, assist with developing community leaders, author position papers, present articles espousing the forward-thinking changes needed to achieve health equity, and liaison with the industry on behalf of the association. Victor will liaison with industry leaders and executives to develop and forge new ideas, opportunities, and relationships for the NMHA with pharma, payers, pharmacies, the medtech industry, and employers.

DYAN BRYSON

Dyan is a patient engagement thought leader and strategist who has been leading the charge for community-driven health equity since 2007. After spending 20+ years in traditional sales, sales leadership, and marketing at Merck and Ciba-Geigy (now Novartis) Dyan has spent the last 15 years laser-focused on patient engagement, patient advocacy, and enhancing diversity in clinical trials. Dyan has designed technology (apps/platforms) that collect patient-reported outcomes (PROs) and developed analytical models to garner the insights necessary to ensure patient centricity from pre-IND through commercialization.  She is also credited with developing and executing the first expansive pharma initiative designed specifically to engage with diverse communities and successfully deliver a significant ROI for commercial therapies. "I look forward to adding my voice to the NMHA's important mission and channeling all of my experience into advancing and championing health equity," said Dyan.

More on The PennZone

• Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
• Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
• Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
• Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
• Spark Announces 2025 Design Award Winners

VICTOR MORRISON

Victor brings over 20 years of pharmaceutical sales, sales management, account management, and marketing management experience with a track record for innovation, leadership, and results, and an additional ten years on the bleeding edge of medtech gaining strategic, product development, marketing, business development, and start-up experience as he focused on commercializing advanced conversational AI for patient engagement.  Victor's passion for health equity in clinical trials was ignited more than two decades ago when he led an institutional sales team whose geography included Jackson Mississippi, where he was exposed to the ongoing work of the Jackson Heart Study, In his role, Victor will help guide the NMHA within the health tech and pharma industries and help ensure that NMHA programs and advocacy are accurate, effective and advance the mission of health equity within the industry. "Joining the NMHA represents an extraordinary opportunity to impact DEI in health care in a significant way.  I am extremely confident that the vision we will be executing will be the crowning achievement of my career in healthcare," said Victor.

"We are thrilled to have professionals such as Dyan and Victor join our team, said Burgess Harrison, NMHA, Executive Director. Both passionately believe in the view that it is each individual's personal right to achieve the best possible health outcome, in particular those in minority and underserved communities. With their vast industry expertise, they are in critical positions to help advance the global mission of health equity within the pharmaceutical and other industries," continued Harrison.

More on The PennZone

• NEW Luxury Single-Family Homes Coming Soon to Manalapan - Pre-Qualify Today for Priority Appointments
• Together We Dance Shines at Newtown Holiday Parade
• Dominic Pace Returns to the NCIS Franchise With Guest Role on NCIS: Origins
• Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
• UK Financial Ltd Completes Full Ecosystem Conversion With Three New ERC-3643 SEC-Ready Tokens As MCAT Deadline Closes Tonight

About NMHA.  The National Minority Health Association, founded in 1988 by Dr. David L. Dalton, Chairman, and CEO, UNIVEC Conglomerate, Inc. (UNVC), achieved its initial mission of ensuring the establishment of Offices of Minority Health in all 50 states. Today the NMHA is adding to its mission, administering an $11.1M HRSA grant to reduce vaccine hesitancy, and deploying new programs that utilize patient-centered, value-based care, and new ways of enhancing care to patients where they are, lowering costs, and improving outcomes for minority and underserved communities. To find out more, visit www.theNMHA.org. Become a member of the NMHA Health Equity Action Leaders network (HEAL) and join the fight for health equity. https://www.thenmha.org/donation.